|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
differentially augments neocortical neuronal activity and excitability
1 Neurology, University Rostock, Rostock, Germany
* To whom correspondence should be addressed. E-mail: ulf.strauss{at}med.uni-rostock.de.
The immunomodulatory cytokine interferon-
(IFN-
) is used in the treatment of autoimmune diseases such as multiple sclerosis. However, the effect of IFN-
on neuronal functions is currently unknown. Intracellular recordings were conducted on somatosensory neurons of neocortical layers 2/3 and 5 exposed to IFN-
. The excitability of neurons was increased by IFN-
(10 - 10,000 U/ml) in two kinetically distinct, putatively independent manners. Firstly, IFN-
reversibly influenced the subthreshold membrane response by raising the membrane resistance RM 2.5-fold and the membrane time constant
1.7-fold dose-dependently. The effect required permanent exposure to IFN-
, and was reduced in magnitude if the extracellular K+ was lowered. However, the membrane response to IFN-
in the subthreshold range was prevented by ZD7288 (a specific blocker of Ih) but not by Ni2+, carbachol or bicuculline, pointing to a dependence on an intact Ih. Secondly, IFN-
enhanced the rate of action potential firing. This effect was observed even after 5 min exposure to IFN-
and showed no reversibility (up to 210 min). Current-discharge (F-I) curves revealed a shift (prevented by bicuculline), as well as an increase in slope (prevented by carbachol and Ni2+). Layer specificity was not observed with any of the described effects.
In conclusion, IFN-
influences the neuronal excitability in neocortical pyramidal neurons in vitro, especially under conditions of slightly increased extracellular K+. Our blocker experiments indicate that various ionic conductances with different voltage-dependencies may cause different influences on sub- and supra-threshold behavior, suggesting a more general intracellular process induced by IFN-
.
This article has been cited by other articles:
![]() |
L L. Mantia, D D'Amico, A Rigamonti, N Mascoli, G Bussone, and C Milanese Interferon treatment may trigger primary headaches in multiple sclerosis patients Multiple Sclerosis, August 1, 2006; 12(4): 476 - 480. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |